| Product Code: ETC9509818 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Deep Vein Thrombosis Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Deep Vein Thrombosis Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Deep Vein Thrombosis Market - Industry Life Cycle |
3.4 Suriname Deep Vein Thrombosis Market - Porter's Five Forces |
3.5 Suriname Deep Vein Thrombosis Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
4 Suriname Deep Vein Thrombosis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of deep vein thrombosis (DVT) cases in Suriname |
4.2.2 Growing awareness about the risks and symptoms of DVT among the population |
4.2.3 Technological advancements in diagnostic tools and treatment options for DVT patients |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare facilities in remote areas of Suriname |
4.3.2 High treatment costs associated with DVT management |
4.3.3 Lack of trained healthcare professionals with expertise in DVT care |
5 Suriname Deep Vein Thrombosis Market Trends |
6 Suriname Deep Vein Thrombosis Market, By Types |
6.1 Suriname Deep Vein Thrombosis Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Suriname Deep Vein Thrombosis Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Suriname Deep Vein Thrombosis Market Revenues & Volume, By Arixtra (Fondaparinux sodium), 2021- 2031F |
6.1.4 Suriname Deep Vein Thrombosis Market Revenues & Volume, By Fragmin (Dalteparin sodium), 2021- 2031F |
6.1.5 Suriname Deep Vein Thrombosis Market Revenues & Volume, By Eliquis (Apixaban), 2021- 2031F |
6.1.6 Suriname Deep Vein Thrombosis Market Revenues & Volume, By Savaysa (Edoxaban), 2021- 2031F |
6.1.7 Suriname Deep Vein Thrombosis Market Revenues & Volume, By Xarelto (Rivaroxaban), 2021- 2031F |
6.1.8 Suriname Deep Vein Thrombosis Market Revenues & Volume, By Abelacimab, 2021- 2031F |
7 Suriname Deep Vein Thrombosis Market Import-Export Trade Statistics |
7.1 Suriname Deep Vein Thrombosis Market Export to Major Countries |
7.2 Suriname Deep Vein Thrombosis Market Imports from Major Countries |
8 Suriname Deep Vein Thrombosis Market Key Performance Indicators |
8.1 Average time from DVT symptom onset to diagnosis |
8.2 Patient adherence rate to prescribed DVT treatment plans |
8.3 Rate of complications or recurrences in DVT patients |
8.4 Number of educational campaigns conducted to raise awareness about DVT prevention and management |
9 Suriname Deep Vein Thrombosis Market - Opportunity Assessment |
9.1 Suriname Deep Vein Thrombosis Market Opportunity Assessment, By Drugs, 2021 & 2031F |
10 Suriname Deep Vein Thrombosis Market - Competitive Landscape |
10.1 Suriname Deep Vein Thrombosis Market Revenue Share, By Companies, 2024 |
10.2 Suriname Deep Vein Thrombosis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here